OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
GNWNYSE67

GENWORTH FINANCIAL INC

Multiline Insurance & BrokersVerified

Genworth Financial maintains a capital structure with total equity of $8.75 billion and total liabilities of $78.32 billion, resulting in a debt-to-equity ratio of 0.0, indicating a relatively low leverage position. The company's liquidity position is currently unassessed due to insufficient balance-sheet inputs and lack of going-concern language in source documents. However, operating cash flow of $327 million in FY2025 suggests some capacity to service obligations and fund operations. Profitability metrics show a return on equity (ROE) of 2.55% and a return on assets (ROA) of 0.25%, both below the industry median for multiline insurers, which typically report ROE in the 5-10% range and ROA in the 1-2% range. This suggests Genworth is underperforming in capital efficiency and asset utilization relative to peers. The company's revenue is concentrated across two segments: Enact, which focuses on mortgage insurance, and Closed Block, which includes long-term care and life insurance. The Enact segment is the primary revenue driver, with the Closed Block segment contributing a smaller but stable portion. However, the company's geographic exposure is primarily domestic, with operations in all 50 U.S. states and the District of Columbia. Looking ahead, Genworth's growth trajectory is expected to be driven by its CareScout division, which is expanding into direct-to-consumer aging care services and funding solutions. The acquisition of Seniorly is expected to accelerate this expansion, with new service offerings like Care Plans and assessments anticipated to generate recurring revenue. FY2025 revenue of $7.3 billion is projected to grow in FY2026, though the exact delta is not yet quantified. Risk factors include high dilution potential, with diluted shares outstanding at 414 million compared to 391.8 million basic shares, indicating a 5.4% dilution risk. The company's liquidity risk remains unassessed, and there is no clear indication of capital preservation strategies in the latest filings. Additionally, the company is involved in litigation with AXA and Santander Cards UK Limited, which could impact future financial condition and liquidity. Recent events include the acquisition of Seniorly to expand the CareScout Quality Network and the launch of new fee-based services. The company also disclosed plans to use any litigation recovery for share repurchases, debt repurchases, and investments in new businesses. Additionally, the FASB issued new accounting guidance in September 2025 that may impact derivative accounting practices.

30-day price · GNW+1.19 (+14.7%)
Low$7.95High$9.45Close$9.28As of18 May, 00:00 UTC
Profile
CompanyGENWORTH FINANCIAL INC
ExchangeNYSE
TickerGNW
CIK0001276520
SICLife Insurance
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryMultiline Insurance & Brokers
AI analysis

Business. Genworth Financial, Inc. offers mortgage and long-term care insurance products through its principal insurance subsidiaries, operating via two segments: Enact, which provides private mortgage insurance in the United States, and Closed Block, which includes long-term care and life insurance products.

Classification. Genworth is classified under the Financials sector, Insurance business sector, and Multiline Insurance & Brokers industry, with a confidence level of 0.92 based on verified market data.

Genworth Financial maintains a capital structure with total equity of $8.75 billion and total liabilities of $78.32 billion, resulting in a debt-to-equity ratio of 0.0, indicating a relatively low leverage position. The company's liquidity position is currently unassessed due to insufficient balance-sheet inputs and lack of going-concern language in source documents. However, operating cash flow of $327 million in FY2025 suggests some capacity to service obligations and fund operations. Profitability metrics show a return on equity (ROE) of 2.55% and a return on assets (ROA) of 0.25%, both below the industry median for multiline insurers, which typically report ROE in the 5-10% range and ROA in the 1-2% range. This suggests Genworth is underperforming in capital efficiency and asset utilization relative to peers. The company's revenue is concentrated across two segments: Enact, which focuses on mortgage insurance, and Closed Block, which includes long-term care and life insurance. The Enact segment is the primary revenue driver, with the Closed Block segment contributing a smaller but stable portion. However, the company's geographic exposure is primarily domestic, with operations in all 50 U.S. states and the District of Columbia. Looking ahead, Genworth's growth trajectory is expected to be driven by its CareScout division, which is expanding into direct-to-consumer aging care services and funding solutions. The acquisition of Seniorly is expected to accelerate this expansion, with new service offerings like Care Plans and assessments anticipated to generate recurring revenue. FY2025 revenue of $7.3 billion is projected to grow in FY2026, though the exact delta is not yet quantified. Risk factors include high dilution potential, with diluted shares outstanding at 414 million compared to 391.8 million basic shares, indicating a 5.4% dilution risk. The company's liquidity risk remains unassessed, and there is no clear indication of capital preservation strategies in the latest filings. Additionally, the company is involved in litigation with AXA and Santander Cards UK Limited, which could impact future financial condition and liquidity. Recent events include the acquisition of Seniorly to expand the CareScout Quality Network and the launch of new fee-based services. The company also disclosed plans to use any litigation recovery for share repurchases, debt repurchases, and investments in new businesses. Additionally, the FASB issued new accounting guidance in September 2025 that may impact derivative accounting practices.
Key takeaways
  • Genworth Financial has a low debt-to-equity ratio of 0.0, indicating a conservative capital structure.
  • The company's ROE of 2.55% and ROA of 0.25% are below industry medians, suggesting underperformance in capital efficiency.
  • Revenue is concentrated in two segments, with Enact being the primary driver and Closed Block contributing a smaller but stable portion.
  • Growth is expected to be driven by CareScout's expansion into direct-to-consumer aging care services and new fee-based offerings.
  • High dilution risk is present, with a 5.4% increase in diluted shares outstanding compared to basic shares.
  • Recent litigation and accounting changes may impact future financial condition and liquidity.
  • --
  • ## RATIONALES
Financial snapshot
PeriodFY2025
CurrencyUSD
Revenue$7.30B
Gross profit
Operating income$41.0M
Net income$223.0M
R&D
SG&A
D&A$231.0M
SBC$58.0M
Operating cash flow$327.0M
CapEx
Free cash flow
Total assets$88.08B
Total liabilities$78.32B
Total equity$8.75B
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2025$7.30B$223.0M
FY2024$7.29B$299.0M
FY2025$7.29B$299.0M
FY2023$7.49B$41.0M$76.0M
FY2024$7.49B$76.0M
PeriodGross %Op %Net %FCF %
FY2025
FY2024
FY2025
FY2023
FY2024
PeriodAssetsEquityCashDebt
FY2025$88.08B$8.75B
FY2024$86.87B$8.49B
FY2025$86.82B$8.44B
FY2023$90.82B$7.48B
FY2024$90.82B$7.48B
PeriodOCFCapExFCFSBC
FY2025$327.0M$58.0M
FY2024$51.0M
FY2025$88.0M$51.0M
FY2023$49.0M
FY2024$49.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q3 2025$5.52B$221.0M
Q2 2025$3.58B$119.0M$105.0M
Q3 2025
Q1 2025$1.79B$51.0M$54.0M
PeriodGross %Op %Net %FCF %
Q3 2025
Q2 2025
Q3 2025
Q1 2025
PeriodAssetsEquityCashDebt
Q3 2025$88.49B$8.81B
Q2 2025$87.34B$8.79B
Q3 2025$9.78B
Q1 2025$87.26B$8.71B
PeriodOCFCapExFCFSBC
Q3 2025$127.0M$42.0M
Q2 2025$40.0M$25.0M
Q3 2025
Q1 2025$34.0M$11.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$9.58B
Net cash
Current ratio
Debt/Equity0.0
ROA0.2%
ROE2.5%
Cash conversion1.5%
CapEx/Revenue
SBC/Revenue0.8%
Asset intensity
Dilution ratio5.7%
Risk assessment
Dilution riskHigh
Liquidity riskUnknown
  • Diluted share count is moderately above the basic share count.
  • Source documents mention dilution or offering risk.
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Asset Management · cohort 1 companies
MetricGNWActivity
Op margin0.6%12.9% medp25 6.7% · p75 19.1%bottom quartile
Net margin3.1%6.9% medp25 2.4% · p75 13.4%below median
Gross margin46.2% medp25 28.1% · p75 79.0%
CapEx / revenue1.5% medp25 1.5% · p75 1.5%
Debt / equity0.0%104.3% medp25 78.1% · p75 130.5%bottom quartile
Observations
IR observations
market data ESG controversies score62.5
market data ESG governance pillar91.0
market data ESG social pillar59.2
market data insider trading score8.0
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
SEC filingstype companyfacts · CIK 0001276520 · 823 us-gaap concepts
2026-05-01 15:18 UTC#b5d6c96b
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 15:20 UTCJob: 28002cf0